- Home
- GDTC vs COCH Comparison
GDTC vs COCH Comparison
Compare GDTC & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDTC
- COCH
- Stock Information
- Founded
- GDTC 2018
- COCH 1995
- Country
- GDTC Singapore
- COCH United States
- Employees
- GDTC N/A
- COCH N/A
- Industry
- GDTC Biotechnology: Pharmaceutical Preparations
- COCH Blank Checks
- Sector
- GDTC Health Care
- COCH Finance
- Exchange
- GDTC Nasdaq
- COCH Nasdaq
- Market Cap
- GDTC 21.5M
- COCH 31.6M
- IPO Year
- GDTC 2023
- COCH N/A
- Fundamental
- Price
- GDTC $1.86
- COCH $1.53
- Analyst Decision
- GDTC Buy
- COCH Strong Buy
- Analyst Count
- GDTC 1
- COCH 2
- Target Price
- GDTC $5.00
- COCH $9.25
- AVG Volume (30 Days)
- GDTC 18.1K
- COCH 28.9K
- Earning Date
- GDTC 01-01-0001
- COCH 08-11-2025
- Dividend Yield
- GDTC N/A
- COCH N/A
- EPS Growth
- GDTC N/A
- COCH N/A
- EPS
- GDTC N/A
- COCH N/A
- Revenue
- GDTC $368,838.00
- COCH $212,000.00
- Revenue This Year
- GDTC $5.37
- COCH $5.93
- Revenue Next Year
- GDTC N/A
- COCH $17.69
- P/E Ratio
- GDTC N/A
- COCH N/A
- Revenue Growth
- GDTC N/A
- COCH N/A
- 52 Week Low
- GDTC $1.20
- COCH $1.21
- 52 Week High
- GDTC $4.05
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- GDTC 35.89
- COCH 47.52
- Support Level
- GDTC $1.85
- COCH $1.60
- Resistance Level
- GDTC $1.95
- COCH $1.60
- Average True Range (ATR)
- GDTC 0.10
- COCH 0.10
- MACD
- GDTC -0.02
- COCH -0.01
- Stochastic Oscillator
- GDTC 23.53
- COCH 24.32
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.